Hepatocellular carcinoma of the intrabiliary growth type

被引:2
作者
Ikeda, Y [1 ]
Matsumata, T [1 ]
Adachi, E [1 ]
Hayashi, H [1 ]
Takenaka, K [1 ]
Sugimachi, K [1 ]
机构
[1] KYUSHU UNIV, FAC MED, DEPT SURG 2, FUKUOKA 812, JAPAN
关键词
hepatocellular carcinoma; intrabiliary growth type; liver resection;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. To determine the optimal surgical therapy for patients with the intrabiliary growth type of hepatocellular carcinoma (HCC), Methods. We evaluated 257 patients with HCC who underwent liver resection from 1981 to 1990 in Kyushu University Hospital. Results. There were 13 (5.1 per cent) with the intrabiliary growth type of HCC, Total bilirubin and r-glutamyl transpeptidase levels were higher (p < 0.05), and diameter of these tumors was larger in patients with intrabiliary growth type of HCC (p < 0.05), There were significant correlations between patients with the intrabiliary growth type of HCC and intrahepatic metastasis (p < 0.01), and port;il vein infiltration (p < 0.01). Survival time of patients with the intrabiliary growth type was significantly shorter than that in the control group (p < 0.05), Nevertheless, two of three patients with the intrabiliary growth type of HCC who underwent resection of more than a 10 mm surgical margin survived for 5 years, respectively. Conclusions. A large number of patients with the intrabiliary growth type of HCC were advanced HCCs with intrahepatic metastasis or portal vein infiltration, However, we favour the view that patients have had a better prognosis if hepatectomy of more than a 10 mm surgical margin had been done.
引用
收藏
页码:76 / 78
页数:3
相关论文
共 25 条
[1]  
[Anonymous], 1989, JPN J SURG, V19, P98
[2]  
[Anonymous], 1990, ANN SURG, V211, P277
[3]  
[Anonymous], HEPATOCELLULAR CARCI
[4]   INTRAHEPATIC RECURRENCE AFTER RESECTION OF HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS [J].
BELGHITI, J ;
PANIS, Y ;
FARGES, O ;
BENHAMOU, JP ;
FEKETE, F .
ANNALS OF SURGERY, 1991, 214 (02) :114-117
[5]  
BRAILEY AG, 1947, NEW ENGL J MED, V237, P643, DOI 10.1056/NEJM194710232371707
[6]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[7]  
2-E
[8]  
EZAKI T, 1989, HEPATO-GASTROENTEROL, V36, P164
[9]   CLINICAL MANIFESTATIONS OF HEPATOMA - REVIEW OF 6 YEARS EXPERIENCE AT A CANCER HOSPITAL [J].
IHDE, DC ;
SHERLOCK, P ;
WINAWER, SJ ;
FORTNER, JG .
AMERICAN JOURNAL OF MEDICINE, 1974, 56 (01) :83-91
[10]  
Ikeda Y, 1995, HEPATO-GASTROENTEROL, V42, P469